Overview
Prulifloxacin has been investigated for the treatment of Urinary Tract Infection.
Indication
用于治疗对普卢利沙星敏感的葡萄球菌、淋球菌、肺炎球菌、肠球菌、莫拉克斯氏菌、大肠杆菌、志贺杆菌、沙门氏菌（伤寒菌、副伤寒菌除外）、柠檬酸细菌、肺炎克雷伯杆菌、沙雷氏菌属、变形杆菌、霍乱弧菌、绿脓杆菌、消化链球菌引起的下列感染： ⑴浅表性皮肤感染症(急性浅表性毛囊炎、传染性脓痂疹)、深层皮肤感染症(蜂窝织炎、丹毒、疖、疖肿症、痈、化脓性甲周炎)、慢性脓皮症(感染性皮脂腺囊肿、化脓等)。 ⑵肛门周围脓肿、外伤和烫伤以及手术创伤等浅表性继发性感染。 ⑶急性上呼吸道感染（咽喉炎、扁桃体炎、急性支气管炎等）、慢性呼吸系统疾病的继发性感染（慢性支气管炎、弥漫性细支气管炎、支气管扩张、肺气肿、肺纤维病、支气管哮喘等）和肺炎。 ⑷膀胱炎、肾盂肾炎、前列腺炎。 ⑸胆囊炎、胆管炎。 ⑹感染性肠炎、细菌性痢疾、沙门氏病、霍乱。 ⑺子宫内感染、子宫附件炎。 ⑻眼睑炎、麦粒肿。 ⑼中耳炎、副鼻窦炎。
Associated Conditions
- Acute Exacerbation of Chronic Obstructive Pulmonary Disease caused by susceptible bacteria
- Acute bacterial sinusitis caused by susceptible bacteria
- Complicated Urinary Tract Infection caused by susceptible bacteria
- Uncomplicated Acute Cystitis caused by susceptible bacteria
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2017/06/28 | Phase 2 | Completed | Aziende Chimiche Riunite Angelini Francesco S.p.A | ||
2015/05/12 | Phase 3 | Completed | Lee's Pharmaceutical Limited | ||
2014/06/06 | Phase 3 | UNKNOWN | Lee's Pharmaceutical Limited | ||
2012/10/19 | Phase 4 | Completed | Fadoi Foundation, Italy | ||
2010/11/01 | Phase 2 | UNKNOWN | |||
2007/03/16 | Phase 3 | Completed | Optimer Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | ||
2006/10/26 | Phase 3 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| No FDA approvals found for this drug. | |||||
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No HSA approvals found for this drug. | |||||
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Health Canada Drug Approvals
Approved Product | Company | DIN | Dosage Form | Strength | Market Date |
|---|---|---|---|---|---|
| No Health Canada approvals found for this drug. | |||||
CIMA AEMPS Drug Approvals
Approved Product | Company | Registration Number | Pharmaceutical Form | Prescription Type | Status |
|---|---|---|---|---|---|
| No CIMA AEMPS (Spain) approvals found for this drug. | |||||
Philippines FDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Philippines FDA approvals found for this drug. | |||||
Saudi SFDA Drug Approvals
Approved Product | Company | License Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Saudi SFDA approvals found for this drug. | |||||
Malaysia NPRA Drug Approvals
Approved Product | Company | Registration Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| No Malaysia NPRA approvals found for this drug. | |||||
UK EMC Drug Information
Medicine Name | MA Holder | MA Number | Pharmaceutical Form | Active Ingredient | Authorization Date |
|---|---|---|---|---|---|
| No UK EMC drug information found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.